Literature DB >> 14670928

Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood.

Betsy Hirsch1, Akiko Shimamura, Lisa Moreau, Shari Baldinger, Maha Hag-alshiekh, Bruce Bostrom, Susan Sencer, Alan D D'Andrea.   

Abstract

The clinical, cytogenetic, and molecular findings of 2 Fanconi anemia (FA) subtype D1 kindreds, initially identified through a young child with a solid tumor (medullobastoma, Wilms tumor), are described. Each kindred subsequently had a second affected child; one developed Wilms tumor followed by a medulloblastoma, and the other developed T-lineage acute lymphoblastic leukemia. Cytogenetic studies revealed an unusually high spontaneous chromosome aberration rate, contrasting with other FA subtypes. Molecular analysis revealed biallelic BRCA2/FANCD1 mutations. The patients did not exhibit bone marrow failure. Our studies suggest that the D1 subtype represents a severe end of the cytogenetic spectrum within FA, consistent with a critical downstream role of BRCA2 in the FA pathway. Furthermore, this FA subgroup may be preferentially associated with an increased predisposition to solid tumors in early childhood. Recognition of this constellation of findings has significant implications for medical management and genetic counseling of FA families.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14670928     DOI: 10.1182/blood-2003-06-1970

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

1.  Enhancement of synthetic lethality via combinations of ABT-888, a PARP inhibitor, and carboplatin in vitro and in vivo using BRCA1 and BRCA2 isogenic models.

Authors:  Caroline C Clark; Jeffrey N Weitzel; Timothy R O'Connor
Journal:  Mol Cancer Ther       Date:  2012-07-09       Impact factor: 6.261

2.  DNA crosslinking damage and cancer - a tale of friend and foe.

Authors:  Yaling Huang; Lei Li
Journal:  Transl Cancer Res       Date:  2013-06       Impact factor: 1.241

3.  Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24.

Authors:  Jung Min Kim; Younghoon Kee; Allan Gurtan; Alan D D'Andrea
Journal:  Blood       Date:  2008-01-03       Impact factor: 22.113

Review 4.  Molecular pathogenesis and clinical management of Fanconi anemia.

Authors:  Younghoon Kee; Alan D D'Andrea
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

5.  Global and disease-associated genetic variation in the human Fanconi anemia gene family.

Authors:  Kai J Rogers; Wenqing Fu; Joshua M Akey; Raymond J Monnat
Journal:  Hum Mol Genet       Date:  2014-08-07       Impact factor: 6.150

6.  Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2.

Authors:  Eloïse Dray; Julia Etchin; Claudia Wiese; Dorina Saro; Gareth J Williams; Michal Hammel; Xiong Yu; Vitold E Galkin; Dongqing Liu; Miaw-Sheue Tsai; Shirley M-H Sy; David Schild; Edward Egelman; Junjie Chen; Patrick Sung
Journal:  Nat Struct Mol Biol       Date:  2010-09-26       Impact factor: 15.369

7.  Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia.

Authors:  Candice Feben; Careni Spencer; Anneline Lochan; Nakita Laing; Karen Fieggen; Engela Honey; Tasha Wainstein; Amanda Krause
Journal:  Fam Cancer       Date:  2017-07       Impact factor: 2.375

Review 8.  PALB2: the hub of a network of tumor suppressors involved in DNA damage responses.

Authors:  Jung-Young Park; Fan Zhang; Paul R Andreassen
Journal:  Biochim Biophys Acta       Date:  2014-07-03

Review 9.  Fanconi anaemia and cancer: an intricate relationship.

Authors:  Grzegorz Nalepa; D Wade Clapp
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

10.  Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin.

Authors:  XiaoZhe Wang; Paul R Andreassen; Alan D D'Andrea
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.